AFP holds online climate digital investigation workshop with journalists in Brazil ahead of COP30

AFP offered a digital investigation workshop for Brazilian journalists on September 29 and October 6, focusing on ways to counter climate misinformation in the run-up to COP30 — the UN climate change conference to be held in Belém in November.

AFP offered a digital investigation workshop for Brazilian journalists on September 29 and October 6, focusing on ways to counter climate misinformation in the run-up to COP30 — the UN climate change conference to be held in Belém in November.
09/02/2026 12:00
NTT Transatel enhances the eSIM Bootstrap Connectivity Experience on the latest Samsung Galaxy Z Series

NTT Transatel, a global cellular connectivity provider and subsidiary of NTT Group, today announced its collaboration with Samsung Electronics Co., Ltd. to enhance the eSIM bootstrap connectivity experience on the Galaxy Z series in the United States. Leveraging NTT Transatel's multi-network eSIM expertise and connectivity platform, the companies are helping simplify smartphone activation by enabling secure connectivity during device setup. The collaboration is designed to help reduce connect...

09/02/2026 12:00
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VH...

09/02/2026 12:00
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim

Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenviron...

09/02/2026 12:00
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. This press relea...

Subscribe to